FI925782L - Bradykinin-antagonister foer behandling av akut pankreatit - Google Patents

Bradykinin-antagonister foer behandling av akut pankreatit Download PDF

Info

Publication number
FI925782L
FI925782L FI925782A FI925782A FI925782L FI 925782 L FI925782 L FI 925782L FI 925782 A FI925782 A FI 925782A FI 925782 A FI925782 A FI 925782A FI 925782 L FI925782 L FI 925782L
Authority
FI
Finland
Prior art keywords
antagonister
pancreatics
bradykin
acute
foer behandling
Prior art date
Application number
FI925782A
Other languages
English (en)
Finnish (fi)
Other versions
FI925782A7 (fi
FI925782A0 (fi
Inventor
Thomas Griesbacher
Fred Lembeck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI925782A0 publication Critical patent/FI925782A0/fi
Publication of FI925782A7 publication Critical patent/FI925782A7/fi
Publication of FI925782L publication Critical patent/FI925782L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/18—Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI925782A 1991-12-21 1992-12-18 Bradykinin-antagonister foer behandling av akut pankreatit FI925782L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91122055 1991-12-21

Publications (3)

Publication Number Publication Date
FI925782A0 FI925782A0 (fi) 1992-12-18
FI925782A7 FI925782A7 (fi) 1993-06-22
FI925782L true FI925782L (fi) 1993-06-22

Family

ID=8207466

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925782A FI925782L (fi) 1991-12-21 1992-12-18 Bradykinin-antagonister foer behandling av akut pankreatit

Country Status (27)

Country Link
US (1) US5670619A (enExample)
EP (1) EP0548825B1 (enExample)
JP (1) JP3588472B2 (enExample)
KR (1) KR930012034A (enExample)
CN (1) CN1073603A (enExample)
AT (1) ATE152733T1 (enExample)
AU (1) AU662188B2 (enExample)
BG (1) BG97168A (enExample)
BR (1) BR9205062A (enExample)
CA (1) CA2085781C (enExample)
CY (1) CY2116B1 (enExample)
CZ (1) CZ375692A3 (enExample)
DE (1) DE69219574T2 (enExample)
DK (1) DK0548825T3 (enExample)
ES (1) ES2101017T3 (enExample)
FI (1) FI925782L (enExample)
GR (1) GR3024179T3 (enExample)
HU (1) HU214056B (enExample)
IL (1) IL104163A0 (enExample)
MA (1) MA22743A1 (enExample)
MX (1) MX9207440A (enExample)
NO (1) NO924925L (enExample)
PL (1) PL297044A1 (enExample)
SI (1) SI9200406A (enExample)
TW (1) TW199863B (enExample)
YU (1) YU108192A (enExample)
ZA (1) ZA929829B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US20040248809A1 (en) * 2003-02-07 2004-12-09 Aventis Pharma Deutschland Gmbh Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
RU2400263C1 (ru) * 2009-04-28 2010-09-27 Евгений Петрович Измайлов Способ консервативного и физиотерапевтического лечения острого панкреатита
RU2425669C1 (ru) * 2010-04-13 2011-08-10 Общество С Ограниченной Ответственностью "Гамаветфарм" Средство для профилактики и лечения острого и хронического панкреатита

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55500520A (enExample) * 1978-07-18 1980-08-14
US4801613A (en) * 1985-06-13 1989-01-31 Nova Technology Limited Partnership Bradykinin antagonist peptides
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
US5162497A (en) * 1987-09-24 1992-11-10 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
EP0451791A2 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft Langwirksame Liposomenpräparate von Peptidarzneistoffen und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
DK0548825T3 (da) 1997-11-03
SI9200406A (en) 1993-06-30
DE69219574T2 (de) 1997-11-13
MA22743A1 (fr) 1993-07-01
AU662188B2 (en) 1995-08-24
DE69219574D1 (de) 1997-06-12
KR930012034A (ko) 1993-07-20
FI925782A7 (fi) 1993-06-22
HU214056B (en) 1997-12-29
ATE152733T1 (de) 1997-05-15
GR3024179T3 (en) 1997-10-31
CN1073603A (zh) 1993-06-30
EP0548825A1 (en) 1993-06-30
JPH05255107A (ja) 1993-10-05
BG97168A (bg) 1993-12-24
ES2101017T3 (es) 1997-07-01
JP3588472B2 (ja) 2004-11-10
NO924925D0 (no) 1992-12-18
MX9207440A (es) 1993-07-01
CY2116B1 (en) 2002-04-26
IL104163A0 (en) 1993-05-13
PL297044A1 (en) 1993-09-06
HUT63336A (en) 1993-08-30
CA2085781C (en) 2003-09-23
ZA929829B (en) 1994-02-16
EP0548825B1 (en) 1997-05-07
US5670619A (en) 1997-09-23
FI925782A0 (fi) 1992-12-18
CZ375692A3 (en) 1993-12-15
TW199863B (enExample) 1993-02-11
HU9204074D0 (en) 1993-04-28
NO924925L (no) 1993-06-22
AU3021292A (en) 1993-06-24
CA2085781A1 (en) 1993-06-22
BR9205062A (pt) 1993-09-28
YU108192A (sh) 1995-12-04

Similar Documents

Publication Publication Date Title
FI922065L (fi) Slutna satsfoerpackningar foer framstaellning av drycker
FI924055L (fi) Foertillverkad sandwichpanel av betong
FI932710L (fi) Foerstaerkt handtag av kartongfodral
FI933580L (fi) Strukturgen av pneumokockprotein
FI912605L (fi) Av skilda moduler hopsaettbar radiotelefon
FI922077L (fi) Foerfarande foer oevervakning av spaorvaexlars skick
FI925323L (fi) Foerfarande foer framstaellning av optiskt aktiva azolfoereningar
FI922642A7 (fi) Foerfarande foer framstaellning av aryletrar
FI923547L (fi) Foerfarande foer avlaegsning av svavel
FI925352A0 (fi) Proteaskatalyserad behandling av lignocellulosamaterial
FI925279A7 (fi) Genomfoerfarande av ackumulatorkontakt
FI930794L (fi) Baerkartong av hylstyp foer artiklar
FI924360L (fi) Enfasigt foerfarande foer framstaellning av diritromycin
FI922930L (fi) Foerfarande foer framstaellning av diacetylrhein
FI933291L (fi) Foerfarande foer paovisning av anti-rna-antikroppar
FI935070A0 (fi) Foerfarande foer framstaellning av klordioxid
FI921573A7 (fi) Borranordning foer framstaellning av spaor uppvisande borrningar
FI920877L (fi) Foerfarande foer utvinning av syre
FI935869L (fi) Foerfarande foer framstaellning av nanopartiklar
FI940250A0 (fi) Foerfarande foer tillverkning av supraledande legeringar
FI921550L (fi) Foerfarande foer belaeggning av en fiberfoerstaerkt plastkropp
FI88701B (fi) Foerfarande foer producering av vaeteperoxid
FI930789L (fi) Foerfarande foer framstaellning av diacetylrein
FI930863A7 (fi) Foerfarande foer framstaellning av styrenplast
FI934022L (fi) Polypeptider deriverade av immunbristvirusets endonukleasprotein